Tigemonam

• Description:

  Tigemonam is a monobactam, a novel orally administered monobactam that protects against gram-negative aerobic bacterial pathogens and is at least as active against clinical isolates of Enterobacteriaceae as amitraz or carmonan (MIC90: 0.06-16 mg/l) .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  437.41

• Molecular Formula:

  C12H15N5O9S2

• Notes:

  Research use only, not for human use.

• Receptor:

  Antibacterial | Antibiotic

• CAS Number:

  102507-71-1